0.790
-0.030
(-3.66%)
Jun 19 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 0.79 - 0.84 |
| 52 week | 0.40 - 1.94 |
| Open | 0.81 |
| Vol / Avg. | 3,482.00/18,495.00 |
| Mkt cap | 11.70M |
| P/E | - |
| Div/yield | - |
| EPS | -0.33 |
| Shares | 14.82M |
| Beta | 0.90 |
| Inst. own | 3% |
Key stats and ratios
| Q3 (Sep '12) | 2012 | |
| Net profit margin | -33.03% | -8.99% |
| Operating margin | -27.72% | -7.74% |
| EBITD margin | - | 0.52% |
| Return on average assets | -38.67% | -10.99% |
| Return on average equity | -71.88% | -19.98% |
| Employees | 225 | - |
| Carbon Disclosure Rating | - | - |
Address
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Dynasil Corporation of America is engaged in the development, marketing and manufacturing of detection, sensing and analysis technology, precision instruments and optical components as well as contract research. The Company�s products and services are used in a range of application markets including the homeland security, industrial and medical markets sectors. The products and services are sold throughout the United States and internationally. The Company operates in four segments: Contract Research, Optics, Instruments and Biomedical. As of September 30, 2012, RMD had a contract backlog of approximately 18 months, of which approximately 42% is through SBIR contracts.
Officers and directors
| Peter Sulick | Independent Chairman of the Board, Interim President and Chief Executive Officer | |
| Thomas C. Leonard | Chief Financial Officer | |
| William K. Hagan Ph.D. | Lead Independent Director | |
| Craig T. Dunham | Director | |
| Alan B. Levine CPA | Director | |
| Lawrence J. Fox | Independent Director | |
| Michael J. Joyner M.D. | Independent Director |